Company intelligence / Profile preview

Cyfuse Biomedical K.K.

Minato-ku, Tokyo, Japancyfusebio.com ↗
Ownership
Private
Employees
~21
Development stage
Preclinical
01

Overview

Bone and cartilage products have advanced to clinical trial stage, while blood vessels and peripheral nerves are in pre-clinical development. Also developing liver structures for drug discovery applications[9].

Therapeutic areas
CardiovascularRheumatology
Modalities
3D cellular productstissue engineering
Industry
Biotech
02

Partnerships

NSK Ltd.universitiesresearch institutesand private companies[10]

Beyond the preview

Go deeper on Cyfuse Biomedical K.K..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyfuse Biomedical K.K..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call